| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.
|
|
Medicine details |
|
| Medicine name | glucagon (Ogluo®) |
| Formulation | 0.5mg in 0.1ml and 1.0 mg in 0.2 ml solution for injection in pre-filled pen |
| Reference number | 5041 |
| Indication | Treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus |
| Company | Tetris Pharma Ltd |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 18/01/2022 |